Literature DB >> 15184438

Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples.

Jonathan A Burton-MacLeod1, Erin M Kane, Rachel S Beard, Leslie A Hadley, Roger I Glass, Tamie Ando.   

Abstract

Two recently commercialized enzyme-linked immunosorbent assay kits, the SRSV(II)-AD (Denka Seiken Co. Ltd., Tokyo, Japan) and IDEIA NLV (DakoCytomation Ltd., Ely, United Kingdom) kits, that detect human norovirus (HuNV) antigens in stool samples were evaluated to assess whether they could be used instead of reverse transcription-PCR (RT-PCR) for routine diagnosis. The sensitivities and specificities of the two kits were tested with a panel of 103 stool samples containing HuNVs of 4 and 10 genetic subgroups within genogroups I and II (GI and GII), respectively, and 39 stool samples containing other enteric viruses. The Denka kit had a high sensitivity (>70% for 10 of the 14 subgroups) but a specificity of only 69%, and the Dako kit had a low sensitivity (<30% for 6 GII subgroups) but a high specificity of 100%. Statistical analysis suggests that HuNVs of four subgroups (subgroups GII/2, GII/5, GII/6, and GII/n) are likely to elude detection by the Dako kit. The two kits also demonstrated differences in reactivities. While the Dako kit discriminated between the GI and GII antigens of HuNVs, the Denka kit cross-reacted with samples containing all GI and GII subgroups of HuNVs. Moreover, the Denka kit also reacted with samples containing human sapovirus (HuSV). We demonstrate that the cross-reactivity of the Denka kit is not due to specific reactions with HuNV and HuSV antigens. These results indicate that neither the Denka kit nor the Dako kit has all the performance characteristics required to replace the RT-PCR methods used to detect HuNVs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184438      PMCID: PMC427881          DOI: 10.1128/JCM.42.6.2587-2595.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Molecular epidemiology of 'Norwalk-like viruses' associated with gastroenteritis outbreaks in New Zealand.

Authors:  G E Greening; M Mirams; T Berke
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

Review 2.  Genetic classification of "Norwalk-like viruses..

Authors:  T Ando; J S Noel; R L Fankhauser
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

3.  Capsid protein diversity among Norwalk-like viruses.

Authors:  J Green; J Vinje; C I Gallimore; M Koopmans; A Hale; D W Brown; J C Clegg; J Chamberlain
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

4.  Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses.

Authors:  S Kobayashi; K Sakae; Y Suzuki; K Shinozaki; M Okada; H Ishiko; K Kamata; K Suzuki; K Natori; T Miyamura; N Takeda
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR.

Authors:  X Jiang; P W Huang; W M Zhong; T Farkas; D W Cubitt; D O Matson
Journal:  J Virol Methods       Date:  1999-12       Impact factor: 2.014

6.  Major change in the predominant type of "Norwalk-like viruses" in outbreaks of acute nonbacterial gastroenteritis in Osaka City, Japan, between April 1996 and March 1999.

Authors:  N Iritani; Y Seto; K Haruki; M Kimura; M Ayata; H Ogura
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

7.  Simultaneous detection and genotyping of "Norwalk-like viruses" by oligonucleotide array in a reverse line blot hybridization format.

Authors:  J Vinjé; M P Koopmans
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

8.  The genome of hawaii virus and its relationship with other members of the caliciviridae.

Authors:  M A Pletneva; S V Sosnovtsev; K Y Green
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

9.  A one-year study of foodborne illnesses in the municipality of Uppsala, Sweden.

Authors:  R Lindqvist; Y Andersson; J Lindbäck; M Wegscheider; Y Eriksson; L Tideström; A Lagerqvist-Widh; K O Hedlund; S Löfdahl; L Svensson; A Norinder
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

10.  Serotype-specific antigen ELISA for detection of Chiba virus in stools.

Authors:  S Kobayashi; K Sakae; K Natori; N Takeda; T Miyamura; Y Suzuki
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

View more
  22 in total

1.  Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus.

Authors:  Verónica Costantini; LaDonna Grenz; Angela Fritzinger; David Lewis; Christianne Biggs; Antony Hale; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

2.  Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens.

Authors:  A Dimitriadis; J A Marshall
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

3.  Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis.

Authors:  Rowena A Bull; Elise T V Tu; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

Review 4.  Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology.

Authors:  Qiu-Hong Wang; Veronica Costantini; Linda J Saif
Journal:  Vaccine       Date:  2006-12-29       Impact factor: 3.641

5.  European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples.

Authors:  Jim J Gray; Evelyne Kohli; Franco M Ruggeri; Harry Vennema; Alicia Sánchez-Fauquier; Eckart Schreier; Chris I Gallimore; Miren Iturriza-Gomara; Helene Giraudon; Pierre Pothier; Ilaria Di Bartolo; Nadia Inglese; Erwin de Bruin; Bas van der Veer; Silvia Moreno; Vanessa Montero; Marí C de Llano; Marina Höhne; Sabine M Diedrich
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

6.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 7.  Norovirus.

Authors:  Elizabeth Robilotti; Stan Deresinski; Benjamin A Pinsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen.

Authors:  Nozomi Sakamaki; Yoshiyuki Ohiro; Mitsuki Ito; Mitsuru Makinodan; Tsubasa Ohta; Wataru Suzuki; Susumu Takayasu; Harufumi Tsuge
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

9.  Microbiologic methods utilized in the MAL-ED cohort study.

Authors:  Eric Houpt; Jean Gratz; Margaret Kosek; Anita K M Zaidi; Shahida Qureshi; Gagandeep Kang; Sudhir Babji; Carl Mason; Ladaporn Bodhidatta; Amidou Samie; Pascal Bessong; Leah Barrett; Aldo Lima; Alexandre Havt; Rashidul Haque; Dinesh Mondal; Mami Taniuchi; Suzanne Stroup; Monica McGrath; Dennis Lang
Journal:  Clin Infect Dis       Date:  2014-11-01       Impact factor: 9.079

10.  Detection of norovirus antigens from recombinant virus-like particles and stool samples by a commercial norovirus enzyme-linked immunosorbent assay kit.

Authors:  Shoko Okitsu-Negishi; Michio Okame; Yuko Shimizu; Tung Gia Phan; Takeshi Tomaru; Shigenori Kamijo; Takashi Sato; Fumihiro Yagyu; Werner E G Müller; Hiroshi Ushijima
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.